Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.

Eisen, A; Fletcher, G G; Gandhi, S; Mates, M; Freedman, O C; Dent, S F; Trudeau, M E

Eisen, A; Fletcher, G G; Gandhi, S; Mates, M; Freedman, O C; Dent, S F; Trudeau, M E.

Afiliación

Eisen A; Sunnybrook Health Science Centre, Toronto, ON.
Fletcher GG; Program in Evidence-Based Care, Cancer Care Ontario; and Department of Oncology, McMaster University, Hamilton, ON.
Gandhi S; Sunnybrook Health Science Centre, Toronto, ON.
Mates M; Cancer Centre of Southeastern Ontario, Kinston General Hospital; and Queen's University, Kingston, ON.
Freedman OC; Durham Regional Cancer Centre, Oshawa, ON.
Dent SF; The Ottawa Hospital Cancer Centre and University of Ottawa, Ottawa, ON.
Trudeau ME; Sunnybrook Health Science Centre, Toronto, ON.

Curr Oncol ; 22(Suppl 1): S67-81, 2015 Mar.

Article en En | MEDLINE | ID: mdl-25848340

Palabras clave

Treatment guidelines; adjuvant systemic treatment; chemotherapy; consensus process; early breast cancer; endocrine therapy; her2-targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Curr Oncol Año: 2015 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google